From: Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway
 | All patients (n = 120) | Patients with adenocarcinoma (n = 44) | Patients with squamous cell carcinoma (n = 76) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sum. (%) | Low(%) | High(%) | P | Sum.(%) | Low(%) | High(%) | P | Sum. (%) | Low (%) | High (%) | P | |
Age (years) | 59.4 ± 8.4 | 59.7 ± 7.9 | 58.8 ± 9.4 | 0.55a | 57.6 ± 7.9 | 56.9 ± 7.8 | 58.8 ± 8.0 | 0.44a | 60.4 ± 8.7 | 61.4 ± 7.5 | 58.8 ± 10.2 | 0.19a |
Gender | Â | Â | Â | 0.66b | Â | Â | Â | 1.00b | Â | Â | Â | 0.24b |
 Male | 92(76.7) | 56(60.9) | 36(39.1) |  | 23(52.3) | 15(65.2) | 8(34.8) |  | 69(90.8) | 41(59.4) | 28(40.6) |  |
 Female | 28(23.3) | 19(67.9) | 9(32.1) |  | 21(47.7) | 13(61.9) | 8(38.1) |  | 7(9.0) | 6(85.7) | 1(14.3) |  |
Depth of invasion | Â | Â | Â | 0.81b | Â | Â | Â | 0.64b | Â | Â | Â | 0.56b |
 T1/T2 | 100(83.3) | 63(63.0) | 37(37.0) |  | 39(88.6) | 24(61.5) | 15(38.5) |  | 61(80.3) | 39(63.9) | 22(36.1) |  |
 T3 | 20(16.7) | 12(60.0) | 8(40.0) |  | 5(11.4) | 4(80.0) | 1(20.0) |  | 15(19.7) | 8(53.3) | 7(46.7) |  |
Lymph node metastasis | Â | Â | Â | 0.45b | Â | Â | Â | 0.01b | Â | Â | Â | 0.48b |
 N0 | 60(50.0) | 35(58.3) | 25(41.7) |  | 24(54.5) | 11(45.8) | 13(54.2) |  | 36(47.4) | 24(66.7) | 12(33.3) |  |
 N1/N2/N3 | 60(50.0) | 40(66.7) | 20(33.3) |  | 20(45.5) | 17(85.0) | 3(15.0) |  | 40(52.6) | 23(57.5) | 17(42.5) |  |
Distant metastasis |  |  |  | 1.00b |  |  |  | 1.00b |  |  |  | – |
 M0 | 119(99.0) | 74(62.2) | 45(37.8) |  | 43(97.7) | 27(62.8) | 16(37.2) |  | 76(100.0) | 47(61.8) | 29(38.2) |  |
 M1 | 1(0.8) | 1(100.0) | 0(0.0) |  | 1(2.3) | 1(100.0) | 0(0.0) |  | 0(0.0) | 0(0.0) | 0(0.0) |  |
TNM stage | Â | Â | Â | 0.19b | Â | Â | Â | 0.09b | Â | Â | Â | 0.94b |
 I | 40(33.3) | 23(57.5) | 17(42.5) |  | 16(36.4) | 8(50.0) | 8(50.0) |  | 24(31.6) | 15(62.5) | 9(37.5) |  |
 II | 65(54.2) | 39(60.0) | 26(40.0) |  | 20(45.5) | 12(60.0) | 8(40.0) |  | 45(59.2) | 27(60.0) | 18(40.0) |  |
 III | 14(11.7) | 12(85.7) | 2(14.3) |  | 7(15.8) | 7(100.0) | 0(0.0) |  | 7(9.2) | 5(71.4) | 2(28.6) |  |
 IV | 1(0.8) | 1(100.0) | 0(0.0) |  | 1(2.3) | 1(100.0) | 0(0.0) |  | 0(0.0) | 0(0.0) | 0(0.0) |  |
Tumor diameter | 4.7 ± 2.2 | 4.7 ± 2.3 | 4.6 ± 2.1 | 0.73 a | 4.0 ± 2.0 | 4.1 ± 2.0 | 3.7 ± 2.0 | 0.54 a | 5.0 ± 2.2 | 5.1 ± 2.4 | 5.0 ± 2.1 | 0.94 a |
Pathology |  |  |  | 1.00b |  |  |  | – |  |  |  | – |
 Adenocarcinoma | 44(36.7) | 28(63.6) | 16(36.4) |  | – | – | – |  | – | – | – |  |
 Squamous cell carcinoma | 76(63.3) | 47(61.8) | 29(38.2) |  | – | – | – |  | – | – | – |  |
Mediam survival time (month) | 32 | 31 | 36 | 0.26 c | 32 | 25 | 47 | 0.04 c | 32 | 35 | 30 | 0.84 c |